Previously, we reported that the sulphated polysaccharides (SPS)-CF, a water-soluble polysaccharide isolated and purified from Korean green alga Maesaengi (Capsosiphon fulvescens, Chlorophyta), is a glucuronogalactomannan based mainly on the monosaccharide composition determined by high-performance liquid chromatography (HPLC) analysis after 1-phenyl-3-methyl-5-pyrazolone (PMP) labelling of sugars in the acid (trifluoroacetic acid (TFA)) hydrolyzates of SPS-CF, which showed mannose (55.4 mol %), galactose (25.3 mol %) and glucuronic acid (16.3 mol %) as major sugars (Na et al., Int Immunopharmacol 10:364-370, 2010). However, the results of the present study re-performed for monosaccharide composition of this polysaccharide using, in addition to HPLC of PMP-labelled sugars, other separation methods, i.e. high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD), gas chromatography with flame ionising detection (GC-FID) and thin-layer chromatography (TLC), clearly demonstrated that the most prominent neutral monosaccharides of SPS-CF are xylose (38.6-49.4 mol %) and rhamnose (39.6-45 mol %), while mannose and galactose are present at a much lesser extent or in negligible amount. These extensive monosaccharide analyses, correlation nuclear magnetic resonance (NMR), electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) measurements confirmed the sulphated glucuronorhamnoxylan (ulvan) type of SPS-CF polysaccharide, whose backbone is composed of alternating sequence of 4-linked L-rhamnose-3-sulphate and D-xylose residues (ulvobiose U3s) carrying monomeric D-glucuronic acid or D-glucuronic acid-3-sulphate on O-2 of some L-rhamnose-3-sulphate units as the side chains. The SPS-CF exhibited significant in vitro anti-coagulant activity by which the activated partial thromboplastin time (aPTT) and thrombin time (TT) were significantly prolonged. The results of this study demonstrated that the ulvan SPS-CF isolated from Korean Maesaengi C. fulvescens can be considered a potential anti-coagulant agent.

Department of Biotechnology and The Research Centre for Biopharmaceutical Lead Molecule The Catholic University of Korea Bucheon Gyeonggi do 420 743 Republic of Korea

Department of Carbohydrate Chemistry and Technology Institute of Chemical Technology Prague Technická 5 166 28 Prague 6 Czech Republic

Department of Pharmaceutical Science Gachon University Yeonsu gu Incheon 406 799 Republic of Korea

Institute of Chemistry Centre for Glycomics Slovak Academy of Sciences Dúbravská cesta 9 845 38 Bratislava Slovakia

Institute of Organic Chemistry and Biochemistry AS CR Flemingovo sq 2 166 28 Prague 6 Czech Republic

Zobrazit více v PubMed

J Biol Chem. 1990 Sep 15;265(26):15403-9 PubMed

Glycoconj J. 1999 Oct;16(10):629-38 PubMed

J Biol Chem. 1996 Oct 25;271(43):26745-54 PubMed

Carbohydr Res. 2012 Nov 1;361:141-7 PubMed

Food Chem Toxicol. 2008 Aug;46(8):2653-7 PubMed

Anal Biochem. 1973 Aug;54(2):484-9 PubMed

Cell Biol Int. 2007 Aug;31(8):768-75 PubMed

Carbohydr Res. 1997 Nov 28;304(3-4):325-33 PubMed

Int J Biol Macromol. 2008 Mar 1;42(2):127-32 PubMed

Chem Biol Interact. 2010 Jan 5;183(1):249-54 PubMed

Arch Pharm Res. 2010 Jan;33(1):125-31 PubMed

Carbohydr Res. 1994 Dec 16;265(2):303-10 PubMed

Anal Biochem. 1982 Jul 1;123(2):303-9 PubMed

Glycoconj J. 1991 Aug;8(4):350-3 PubMed

Molecules. 2008 Aug 12;13(8):1671-95 PubMed

Biochem J. 1971 Dec;125(4):1009-18 PubMed

Biochemistry. 2004 Aug 31;43(34):11063-74 PubMed

J Biol Chem. 1985 Feb 10;260(3):1849-57 PubMed

Thromb Res. 1976 Dec;9(6):575-83 PubMed

Carbohydr Res. 2002 Sep 27;337(17):1553-62 PubMed

Carbohydr Res. 1999 Jun 30;319(1-4):154-65 PubMed

Glycobiology. 1995 Dec;5(8):807-11 PubMed

Mar Biotechnol (NY). 2011 Jun;13(3):433-40 PubMed

J Biol Chem. 2010 Mar 5;285(10):7312-23 PubMed

J Biol Chem. 1989 May 25;264(15):8692-8 PubMed

Carbohydr Res. 1992 Nov 4;235:309-11 PubMed

Carbohydr Polym. 2012 Nov 6;90(4):1804-10 PubMed

Int J Biol Macromol. 2001 Jun 12;28(5):395-9 PubMed

Anal Biochem. 1989 Aug 1;180(2):351-7 PubMed

Int Immunopharmacol. 2010 Mar;10 (3):364-70 PubMed

Biomacromolecules. 2007 Jun;8(6):1765-74 PubMed

Int J Biol Macromol. 1999 Nov;26(2-3):151-4 PubMed

J Biol Chem. 2011 Dec 9;286(49):42063-71 PubMed

Adv Carbohydr Chem Biochem. 1967;22:25-108 PubMed

Indian J Exp Biol. 2001 Apr;39(4):365-70 PubMed

Anal Biochem. 1994 Jun;219(2):278-87 PubMed

Glycobiology. 2003 Jun;13(6):29R-40R PubMed

Trends Cardiovasc Med. 1999 Nov;9(8):225-32 PubMed

Anal Biochem. 1976 May 7;72:248-54 PubMed

Carbohydr Res. 1996 Mar 22;283:161-73 PubMed

Front Plant Sci. 2012 May 08;3:82 PubMed

Chem Pharm Bull (Tokyo). 2004 Sep;52(9):1091-4 PubMed

Bull Exp Biol Med. 2007 Jun;143(6):730-2 PubMed

Anal Biochem. 1994 Jun;219(2):375-8 PubMed

Hemodial Int. 2007 Apr;11(2):178-89 PubMed

Carbohydr Res. 1998 Dec 21;314(1-2):1-12 PubMed

Int J Biol Macromol. 2012 Dec;51(5):720-9 PubMed

J Biol Chem. 1996 Jul 26;271(30):17711-7 PubMed

Low Molecular Weight Mannogalactofucans Derived from Undaria pinnatifida Induce Apoptotic Death of Human Prostate Cancer Cells In Vitro and In Vivo